Abstract
635 In selected severe cases of terminal heart failure refractory to standard pharmacological treatment, total artificial heart (TAH) can be used as a bridge to heart transplantation (HT). In our institution, between March 1, 1984 to December 31, 1996 we implanted 25 TAHs in patients who were subsequently transplanted. Prior to July 1, 1994, we implanted 17 Jarvik 7 TAH(Group I) and since then 8 Cardiowest TAH (Group II) in patients who subsequently received HT. TableConclusions: One year survival in patients with TAH support before HT is better with the Cardiowest when compared to the older Jarvik 7 model. In addition, length of hospital stay post-HT is significantly shorter. This experience also illustrates the benefits of careful patient selection, especially at the time of the shortage of organ donors. Further study of the reasons for this improved survival with Cardiowest TAH is necessary.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
